Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome

NCT03047993

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Blasts 20-30 Percent of Peripheral Blood White Cells, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)

NCT04942730

Conditions: Biphenotypic Acute Leukemia, Bone Marrow Diseases, Hematologic Diseases, +19 more
Locations: RM Gorbacheva Research Institute Saint Petersburg, Russia

View Trial Details

Completed

Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers

NCT01597219

Conditions: Acquired Bone Marrow Failure Syndromes, Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, +33 more
Locations: Birmingham Heartlands Birmingham, United Kingdom

Bristol Royal Infirmary Bristol, United Kingdom

Addenbrooke's Hospital Cambridge, United Kingdom

Beatson Hospital Glasgow, United Kingdom

View Trial Details

Completed

Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes

NCT01913951

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation

NCT02981914

Conditions: Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Bone Marrow Diseases, +16 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

NCT04202003

Conditions: Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

Peking University International Hospital Beijing, Beijing Municipality, China

Beijing Boren Hospital Beijing, Beijing Municipality, China

The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China

View all 26 locations

View Trial Details

Completed

Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide

NCT06069024

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +16 more
Locations: the First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China

View Trial Details

Completed

SARS-CoV-2 Donor-Recipient Immunity Transfer

NCT04666025

Conditions: Accelerated Phase CML, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +53 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations

NCT03433781

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: University of Miami Miller School of Medicine -Sylvester Cancer Center Miami, Florida, United States

New York University School of Medicine New York, United States

View Trial Details

Completed

A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving

NCT01684150

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
Locations: Mayo Clinic Scottsdale-Phoenix Scottsdale, Arizona, United States

Northwestern University Chicago, Illinois, United States

Memorial Sloan Kettering Cancer Center New York, United States

Duke University Health System Durham, North Carolina, United States

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions